相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I study of glypican-3-derived peptide vaccine therapy for patients with refractory pediatric solid tumors
Nobuhiro Tsuchiya et al.
ONCOIMMUNOLOGY (2018)
Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database
Kirsten L. Moek et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Time-to-event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma
Mikiko Nakamura et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Cancer immunotherapy-targeted glypican-3 or neoantigens
Yasuhiro Shimizu et al.
CANCER SCIENCE (2018)
Overexpression of glypican-3 is a predictor of poor prognosis in hepatocellular carcinoma An updated meta-analysis
Jian Zhang et al.
MEDICINE (2018)
Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab
Gong Chen et al.
Oncotarget (2018)
Mutation update for the GPC3 gene involved in Simpson-Golabi-Behmel syndrome and review of the literature (vol 39, pg 790, 2018)
Marie-Laure Vuillaume et al.
HUMAN MUTATION (2018)
Genomic Analysis of Hepatoblastoma Identifies Distinct Molecular and Prognostic Subgroups
Pavel Sumazin et al.
HEPATOLOGY (2017)
Markers of Hippo-Pathway Activity in Tumor Forming Liver Lesions
Henning Reis et al.
PATHOLOGY & ONCOLOGY RESEARCH (2017)
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
Chunguang Wang et al.
ONCOTARGET (2017)
Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity
Wenpeng Li et al.
HUMAN GENE THERAPY (2017)
Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma
Nan Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors
Takahiro Ishiguro et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Glypican 3 as a Serum Marker for Hepatoblastoma
Shengmei Zhou et al.
SCIENTIFIC REPORTS (2017)
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
Sarah E. Woodfield et al.
SCIENTIFIC REPORTS (2017)
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R. Bosse et al.
CANCER CELL (2017)
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies
Sayed Shahabuddin Hoseini et al.
CANCER LETTERS (2017)
Combining ERY974, a novel Tcell-redirecting bispecific antibody targeting glypican-3, with chemotherapy profoundly improved antitumor efficacy over its monotherapy in xenograft model
Yuji Sano et al.
CANCER RESEARCH (2017)
Phase Ib study of codrituzumab in combination with sorafenib in patients with non-curable advanced hepatocellular carcinoma (HCC)
Ghassan K. Abou-Alfa et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas
Giuliana Cassinelli et al.
CANCER LETTERS (2016)
Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma
Ghassan K. Abou-Alfa et al.
JOURNAL OF HEPATOLOGY (2016)
Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
Shiro Suzuki et al.
OncoImmunology (2016)
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
Yu Sawada et al.
ONCOIMMUNOLOGY (2016)
Quantification of glypican 3, β-catenin and claudin-1 protein expression in hepatoblastoma and paediatric hepatocellular carcinoma by colour deconvolution
Shengmei Zhou et al.
HISTOPATHOLOGY (2015)
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Renato V. Iozzo et al.
MATRIX BIOLOGY (2015)
Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis
Wei Gao et al.
NATURE COMMUNICATIONS (2015)
Glypican 3 Expression in Pediatric Malignant Solid Tumors
Yoshiaki Kinoshita et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2015)
Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells
Wei Gao et al.
PLOS ONE (2015)
Glypican 3 overexpression in primary and metastatic Wilms tumors
Maria Tretiakova et al.
VIRCHOWS ARCHIV (2015)
Japanese phase I study of GC33, a humanized antibody against glypican-3 for advanced hepatocellular carcinoma
Masafumi Ikeda et al.
CANCER SCIENCE (2014)
WNT/β-Catenin Signaling and Hepatocellular Carcinoma
Jack R. Wands et al.
HEPATOLOGY (2014)
Inactivation of Wnt Signaling by a Human Antibody That Recognizes the Heparan Sulfate Chains of Glypican-3 for Liver Cancer Therapy
Wei Gao et al.
HEPATOLOGY (2014)
Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling
Mariana Capurro et al.
JOURNAL OF CELL SCIENCE (2014)
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth
Erik H. Knelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Simpson-Golabi-Behmel syndrome types I and II
Jair Tenorio et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
First-in-Man Phase I Study of GC33, a Novel Recombinant Humanized Antibody Against Glypican-3, in Patients with Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
CLINICAL CANCER RESEARCH (2013)
Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression
Kenichi Kohashi et al.
HUMAN PATHOLOGY (2013)
Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP
Hui-Lai Miao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Immunohistochemical Expression of Glypican-3 in Pediatric Tumors: An Analysis of 414 Cases
Elaine S. Chan et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2013)
Therapeutically targeting glypican-3 via a conformation-specific single-domain antibody in hepatocellular carcinoma
Mingqian Feng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
High-affinity monoclonal antibodies to cell surface tumor antigen glypican-3 generated through a combination of peptide immunization and flow cytometry screening
Yen Phung et al.
MABS (2012)
Malignant Rhabdoid Tumors Express Stem Cell Factors, Which Relate To the Expression of EZH2 and Id Proteins
Sriram Venneti et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
Glypican-5 stimulates rhabdomyosarcoma cell proliferation by activating Hedgehog signaling
Fuchuan Li et al.
JOURNAL OF CELL BIOLOGY (2011)
Glypican-3 is expressed in rhabdomyosarcomas but not adult spindle cell and pleomorphic sarcomas
Khin Thway et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker et al.
BLOOD (2010)
Wnt/β-catenin signaling in hepatic organogenesis
Kari Nejak-Bowen et al.
Organogenesis (2010)
Wnt signaling in kidney development and disease
Kaisa Pulkkinen et al.
Organogenesis (2010)
The Wnt/β-catenin signaling pathway in liver biology and disease
Jaideep Behari
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Expression of glypican 3 in ovarian and extragonadal germ cell tumors
Debra L. Zynger et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary
Ghada E. Esheba et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Anti-Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer
Takahiro Ishiguro et al.
CANCER RESEARCH (2008)
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
Wei Cheng et al.
CARCINOGENESIS (2008)
Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding
Mariana I. Capurro et al.
DEVELOPMENTAL CELL (2008)
Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases
Debra L. Zynger et al.
HUMAN PATHOLOGY (2008)
Glypican 3: A novel marker in testicular germ cell tumors
Debra L. Zynger et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma
N Yamauchi et al.
MODERN PATHOLOGY (2005)
Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling
MI Capurro et al.
CANCER RESEARCH (2005)
The loss of glypican-3 induces alterations in wnt signaling
HH Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Methylation analysis of the glypican 3 gene in embryonal tumours
G Boily et al.
BRITISH JOURNAL OF CANCER (2004)
Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells
A Wichert et al.
ONCOGENE (2004)
Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt signaling, and gastrulation movements
B De Cat et al.
JOURNAL OF CELL BIOLOGY (2003)
Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
T Nakatsura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Somatic glypican 3 (GPC3) mutations in Wilms' tumour
GRM White et al.
BRITISH JOURNAL OF CANCER (2002)
Glypican-3 expression in Wilms tumor and hepatoblastoma
JA Toretsky et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2001)
Glypicans in growth control and cancer
J Filmus
GLYCOBIOLOGY (2001)
分享论文
